• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主要在平滑肌细胞中表达的非载脂蛋白E(APOE)变体,对阿尔茨海默病遗传风险对白质高信号的影响有作用。

Non-APOE variants predominately expressed in smooth muscle cells contribute to the influence of Alzheimer's disease genetic risk on white matter hyperintensities.

作者信息

Chandler Hannah Louise, Wheeler Joshua, Escott-Price Valentina, Murphy Kevin, Lancaster Thomas Matthew

机构信息

School of Physics and Astronomy, Cardiff University Brain Research Imaging Centre (CUBRIC), Cardiff University, Cardiff, UK.

School of Clinical Sciences, University of Bristol, Bristol, UK.

出版信息

Alzheimers Dement. 2025 Feb;21(2):e14455. doi: 10.1002/alz.14455. Epub 2024 Dec 31.

DOI:10.1002/alz.14455
PMID:39737667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11848156/
Abstract

INTRODUCTION

White matter hyperintensity volumes (WMHVs) are disproportionally prevalent in individuals with Alzheimer's disease (AD), potentially reflecting neurovascular injury. We quantify the association between AD polygenic risk score (AD-PRS) and WMHV, exploring single-nucleotide polymorphisms (SNPs) that are proximal to genes overexpressed in cerebrovascular cell species.

METHODS

In a UK-Biobank sub-sample (mean age = 64, range = 45-81 years), we associate WMHV with (1) AD-PRS estimated via SNPs across the genome (minus apolipoprotein E [APOE] locus) and (2) AD-PRS estimated with SNPs proximal to specific genes that are overexpressed in cerebrovascular cell species.

RESULTS

We observed a positive association between non-APOE-AD-PRS and WMHVs. We further demonstrate an association between WMHVs and AD-PRS constructed with SNPs that are proximal to genes over-represented in smooth muscles cells (SMCs; β = 0.135, P < 0.01) and internally replicated (P< 0.01).

DISCUSSION

Common AD genetic risk could explain physiological processes underlying vascular pathology in AD. SMC function may offer a treatment target to prevent WMHV-related AD pathophysiology prior to the onset of symptoms.

HIGHLIGHTS

Alzheimer's disease (AD) risk factors such as apolipoprotein E (APOE) ε4, link to increased white matter hyperintensity volume (WMHV). WMHVs indicate vascular risk and neurovascular injury in AD. The broader genetic link between AD risk and WMHV is not fully understood. We quantify AD polygenic risk score (PRS) associations with WMHV, excluding APOE. AD-PRS in smooth muscle cells (SMCs) shows a significant association with increased WMHV.

摘要

引言

白质高信号体积(WMHV)在阿尔茨海默病(AD)患者中普遍存在,可能反映神经血管损伤。我们量化了AD多基因风险评分(AD-PRS)与WMHV之间的关联,探索与脑血管细胞中过表达基因邻近的单核苷酸多态性(SNP)。

方法

在英国生物银行的一个子样本(平均年龄=64岁,范围=45-81岁)中,我们将WMHV与(1)通过全基因组SNP估计的AD-PRS(减去载脂蛋白E [APOE]基因座)以及(2)用脑血管细胞中过表达的特定基因邻近的SNP估计的AD-PRS相关联。

结果

我们观察到非APOE-AD-PRS与WMHV之间存在正相关。我们进一步证明了WMHV与用平滑肌细胞(SMC)中过表达基因邻近的SNP构建的AD-PRS之间的关联(β=0.135,P<0.01),并在内部重复验证(P<0.01)。

讨论

常见的AD遗传风险可以解释AD血管病理的生理过程。SMC功能可能为在症状出现之前预防与WMHV相关的AD病理生理提供一个治疗靶点。

要点

阿尔茨海默病(AD)的风险因素如载脂蛋白E(APOE)ε4与白质高信号体积(WMHV)增加有关。WMHV表明AD中的血管风险和神经血管损伤。AD风险与WMHV之间更广泛的遗传联系尚未完全了解。我们量化了排除APOE的AD多基因风险评分(PRS)与WMHV的关联。平滑肌细胞(SMC)中的AD-PRS与WMHV增加显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b447/11848156/0db26ae544ab/ALZ-21-e14455-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b447/11848156/8ba2e68869f6/ALZ-21-e14455-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b447/11848156/0db26ae544ab/ALZ-21-e14455-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b447/11848156/8ba2e68869f6/ALZ-21-e14455-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b447/11848156/0db26ae544ab/ALZ-21-e14455-g002.jpg

相似文献

1
Non-APOE variants predominately expressed in smooth muscle cells contribute to the influence of Alzheimer's disease genetic risk on white matter hyperintensities.主要在平滑肌细胞中表达的非载脂蛋白E(APOE)变体,对阿尔茨海默病遗传风险对白质高信号的影响有作用。
Alzheimers Dement. 2025 Feb;21(2):e14455. doi: 10.1002/alz.14455. Epub 2024 Dec 31.
2
Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults.认知未受损成年人的阿尔茨海默病遗传风险与脑萎缩及白质高信号的变化
Brain Commun. 2024 Aug 14;6(5):fcae276. doi: 10.1093/braincomms/fcae276. eCollection 2024.
3
Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.淀粉样蛋白-β和 APOE 基因型可独立于阿尔茨海默病多基因风险评分预测认知正常的老年人的记忆下降。
BMC Neurol. 2022 Dec 15;22(1):484. doi: 10.1186/s12883-022-02925-6.
4
Association of -Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults.独立阿尔茨海默病多基因风险评分与无症状老年人大脑淀粉样蛋白沉积的关联。
Neurology. 2022 Aug 1;99(5):e462-e475. doi: 10.1212/WNL.0000000000200544.
5
Polygenic risk discriminates Lewy body dementia from Alzheimer's disease.多基因风险可区分路易体痴呆与阿尔茨海默病。
Alzheimers Dement. 2025 Feb;21(2):e14381. doi: 10.1002/alz.14381. Epub 2025 Jan 24.
6
Polygenic risk and hazard scores for Alzheimer's disease prediction.多基因风险和阿尔茨海默病预测的危害评分。
Ann Clin Transl Neurol. 2019 Feb 18;6(3):456-465. doi: 10.1002/acn3.716. eCollection 2019 Mar.
7
Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.多基因风险评分对轻度认知障碍进展为痴呆的预测能力及其与 APOE ε4 的相互作用。
Transl Neurodegener. 2021 Aug 31;10(1):32. doi: 10.1186/s40035-021-00259-w.
8
Association of genetic risk of Alzheimer's disease and cognitive function in two European populations.两个欧洲人群中阿尔茨海默病遗传风险与认知功能的关联
Sci Rep. 2025 Feb 21;15(1):6410. doi: 10.1038/s41598-025-90277-9.
9
The effect of Alzheimer's disease genetic factors on limbic white matter microstructure.阿尔茨海默病遗传因素对边缘系统白质微观结构的影响。
Alzheimers Dement. 2025 Apr;21(4):e70130. doi: 10.1002/alz.70130.
10
Association of APOE alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer's disease neuroimaging markers.APOE等位基因与包含APOE-TOMM40-APOC1变体的多基因谱与阿尔茨海默病神经影像标志物的关联
Alzheimers Dement. 2025 Feb;21(2):e14445. doi: 10.1002/alz.14445. Epub 2024 Dec 23.

本文引用的文献

1
Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals.阿尔茨海默病的遗传途径影响非痴呆个体的脑脊液生物标志物和影像学内表型。
Alzheimers Dement. 2024 Sep;20(9):6146-6160. doi: 10.1002/alz.14096. Epub 2024 Jul 29.
2
Genetic Complexities of Cerebral Small Vessel Disease, Blood Pressure, and Dementia.脑小血管病、血压和痴呆的遗传复杂性。
JAMA Netw Open. 2024 May 1;7(5):e2412824. doi: 10.1001/jamanetworkopen.2024.12824.
3
Atherosclerosis Is a Smooth Muscle Cell-Driven Tumor-Like Disease.
动脉粥样硬化是一种平滑肌细胞驱动的肿瘤样疾病。
Circulation. 2024 Jun 11;149(24):1885-1898. doi: 10.1161/CIRCULATIONAHA.123.067587. Epub 2024 Apr 30.
4
Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.将脑白质高信号与阿尔茨海默病的区域性皮质变薄、淀粉样蛋白沉积和突触密度丧失联系起来。
Alzheimers Dement. 2024 Jun;20(6):3931-3942. doi: 10.1002/alz.13845. Epub 2024 Apr 22.
5
A comprehensive analysis of APOE genotype effects on human brain structure in the UK Biobank.英国生物银行中APOE基因分型对人类大脑结构影响的综合分析。
Transl Psychiatry. 2024 Mar 12;14(1):143. doi: 10.1038/s41398-024-02848-5.
6
Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease.细胞类型特异性阿尔茨海默病多基因风险评分与阿尔茨海默病的不同疾病进程相关。
Nat Commun. 2023 Nov 30;14(1):7659. doi: 10.1038/s41467-023-43132-2.
7
Evaluating the Classification Accuracy of Expression Quantitative Trait Loci Calculated Polygenic Risk Scores in Alzheimer's Disease.评估阿尔茨海默病中基于表达数量性状基因座计算的多基因风险评分的分类准确性。
Int J Mol Sci. 2023 Aug 14;24(16):12799. doi: 10.3390/ijms241612799.
8
Transcriptional risk scores in Alzheimer's disease: From pathology to cognition.阿尔茨海默病的转录风险评分:从病理学到认知。
Alzheimers Dement. 2024 Jan;20(1):243-252. doi: 10.1002/alz.13406. Epub 2023 Aug 10.
9
White matter hyperintensities in Alzheimer's disease: Beyond (but not instead of) the vascular contribution.阿尔茨海默病中的白质高信号:超越(但并非取代)血管因素的影响
Alzheimers Dement. 2023 Sep;19(9):4262-4263. doi: 10.1002/alz.13372. Epub 2023 Jul 12.
10
Biomarkers Assessing Endothelial Dysfunction in Alzheimer's Disease.评估阿尔茨海默病患者血管内皮功能障碍的生物标志物。
Cells. 2023 Mar 22;12(6):962. doi: 10.3390/cells12060962.